title: Optimal dosing of rivaroxaban is undefined.
authors.affiliation: Institute for Safe Medication Practices, 101 N Columbus St, Suite 410, Alexandria, VA 22314, USA.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Moore
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D065427:Factor Xa Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D000069552:Rivaroxaban / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban